ASLAN Pharmaceuticals Limited Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$2.56 | -$2.56 | -$2.56 |
| Q2 2024 | 1 | -$0.17 | -$0.15 | -$0.16 |
| Q3 2024 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q4 2024 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q1 2025 | 1 | -$4.40 | -$4.40 | -$4.40 |
| Q2 2025 | 1 | -$4.64 | -$4.64 | -$4.64 |
| Q3 2025 | 1 | -$4.80 | -$4.80 | -$4.80 |
| Q4 2025 | 1 | -$5.04 | -$5.04 | -$5.04 |
ASLAN Pharmaceuticals Limited Earnings Date And Information
ASLAN Pharmaceuticals Limited last posted its earnings results on Friday, August 9th, 2024. The company reported $-0.88 earnings per share for the quarter, topping analysts' consensus estimates of $-3.8 by $2.92. The company had revenue of 0 for the quarter and had revenue of 12.00 M for the year. ASLAN Pharmaceuticals Limited has generated $-3 earnings per share over the last year ($-2.69 diluted earnings per share) and currently has a price-to-earnings ratio of -0.32. ASLAN Pharmaceuticals Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based on prior year's report dates.
ASLAN Pharmaceuticals Limited Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/30/2024 | Q1 2024 | -$0.53 | $0 | $0 | ||
| 04/12/2024 | Q4 2023 | -$0.78 | $0 | |||
| 08/18/2023 | Q3 2023 | -$0.56 | $0 | |||
| 08/18/2023 | Q2 2023 | -$0.11 | $12.00 M | |||
| 03/31/2023 | Q1 2023 | -$1.29 | $0 | |||
| 03/24/2023 | Q4 2022 | -$7.60 | -$1.04 | 6.56 | $0 | |
| 09/29/2022 | Q3 2022 | -$0.78 | $0 | |||
| 06/29/2022 | Q2 2022 | -$0.92 | $0 | |||
| 03/31/2022 | Q1 2022 | -$0.92 | $0 | |||
| 03/25/2022 | Q4 2021 | -$6.00 | -$0.66 | 5.34 | $0 | |
| 09/29/2021 | Q3 2021 | -$0.61 | $0 | |||
| 08/06/2021 | Q2 2021 | -$4.40 | -$0.39 | 4.01 | $0 | |
| 01/29/2021 | Q1 2021 | -$0.65 | $0 | |||
| 04/23/2021 | Q4 2020 | -$0.72 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.43 | $0 | |||
| 10/09/2020 | Q2 2020 | -$0.52 | $0 | |||
| 03/31/2020 | Q1 2020 | -$0.40 | $0 | |||
| 04/16/2020 | Q4 2019 | -$4.39 | $0 | |||
| 10/31/2019 | Q3 2019 | -$8.80 | -$0.81 | 7.99 | $0 | |
| 10/31/2019 | Q2 2019 | -$8.80 | -$1.24 | 7.56 | $0 |
ASLAN Pharmaceuticals Limited Earnings: Frequently Asked Questions
-
When is ASLAN Pharmaceuticals Limited's earnings date?
ASLAN Pharmaceuticals Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates.
-
Did ASLAN Pharmaceuticals Limited beat their earnings estimates last quarter?
In the previous quarter, ASLAN Pharmaceuticals Limited (:ASLN) reported $-0.88 earnings per share (EPS) to beat the analysts' consensus estimate of $-3.8 by $2.92.
-
How can I listen to ASLAN Pharmaceuticals Limited's earnings conference call?
The conference call for ASLAN Pharmaceuticals Limited's latest earnings report can be listened to online.
-
How can I read ASLAN Pharmaceuticals Limited's conference call transcript?
The conference call transcript for ASLAN Pharmaceuticals Limited's latest earnings report can be read online.
-
How much revenue does ASLAN Pharmaceuticals Limited generate each year?
ASLAN Pharmaceuticals Limited (:ASLN) has a recorded annual revenue of $12.00 M.
-
How much profit does ASLAN Pharmaceuticals Limited generate each year?
ASLAN Pharmaceuticals Limited (:ASLN) has a recorded net income of $12.00 M. ASLAN Pharmaceuticals Limited has generated $-2.69 earnings per share over the last four quarters.
-
What is ASLAN Pharmaceuticals Limited's price-to-earnings ratio?
ASLAN Pharmaceuticals Limited (:ASLN) has a price-to-earnings ratio of -0.32 and price/earnings-to-growth ratio is -0.01.
